A year ago, KFI announced the approval of Solensia® to Zoetis by the European Commission. We are now happy to report that this unique treatment for feline osteoarthritic pain, has been approved by CVM. This is the first monoclonal antibody new animal drug approved for use in any species. KFI is proud to have carried out the pre-clinical safety study for this drug.
Zoetis – Zoetis Announces FDA Approval of Solensia™ (frunevetmab injection) to Control Osteoarthritis Pain in Cats